D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$354M |
| 2 |
Wells Fargo
WFC
|
+$274M |
| 3 |
IBM
IBM
|
+$266M |
| 4 |
Qualcomm
QCOM
|
+$257M |
| 5 |
Mondelez International
MDLZ
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$356M |
| 2 |
PayPal
PYPL
|
+$290M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$261M |
| 4 |
NVIDIA
NVDA
|
+$248M |
| 5 |
AABA
Altaba Inc
AABA
|
+$245M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.61% |
| 2 | Healthcare | 10.26% |
| 3 | Consumer Discretionary | 10.07% |
| 4 | Financials | 8.17% |
| 5 | Communication Services | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
REV
2851
CALL
DELISTED
Revlon, Inc.
REV
| $520K | ﹤0.01% |
21,200
+200
| +1% | +$3.87K |
|
2852
Home BancShares
HOMB
$6.21B
| $519K | ﹤0.01% |
20,562
-95,146
| -82% | -$2.29M |
|
2853
Nektar Therapeutics
NKTR
$2.39B
| $519K | ﹤0.01% |
1,443
-7,610
| -84% | -$2.38M |
|
|
DRD
2854
DRDGold
DRD
$1.82B
| $518K | ﹤0.01% |
134,600
-112,049
| -45% | -$378K |
|
2855
CALL
Advanced Energy
AEIS
$12.2B
| $517K | ﹤0.01% |
6,400
| – | – |
|
2856
Supernus Pharmaceuticals
SUPN
$2.68B
| $514K | ﹤0.01% |
12,852
-4,396
| -25% | -$190K |
|
|
SIOX
2857
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $513K | ﹤0.01% |
9,324
-201,593
| -96% | -$34M |
|
|
FBR
2858
DELISTED
Fibria Celulose Sa
FBR
| $513K | ﹤0.01% |
+37,885
| New | +$450K |
|
2859
Designer Brands
DBI
$277M
| $512K | ﹤0.01% |
23,826
+84
| +0.4% | +$1.54K |
|
2860
TTEC Holdings
TTEC
$103M
| $512K | ﹤0.01% |
12,253
-9,393
| -43% | -$380K |
|
|
CBF
2861
DELISTED
Capital Bank Financial Corp. Class A Common Stock
CBF
| $511K | ﹤0.01% |
12,453
+3,835
| +44% | +$146K |
|
2862
Novavax
NVAX
$1.23B
| $509K | ﹤0.01% |
22,305
-253,177
| -92% | -$5.67M |
|
2863
Compass Minerals
CMP
$1.24B
| $505K | ﹤0.01% |
7,785
-14,789
| -66% | -$988K |
|
2864
Nutanix
NTNX
$14.9B
| $505K | ﹤0.01% |
22,553
+11,024
| +96% | +$241K |
|
|
GFN
2865
DELISTED
General Finance Corporation
GFN
| $505K | ﹤0.01% |
100,000
| – | – |
|
2866
Dime Commercial Bancshares
DCOM
$1.75B
| $504K | ﹤0.01% |
14,841
-553
| -4% | -$17.7K |
|
|
PFSW
2867
DELISTED
PFSweb, Inc.
PFSW
| $503K | ﹤0.01% |
60,240
+12,639
| +27% | +$100K |
|
|
SSI
2868
DELISTED
Stage Stores Inc
SSI
| $501K | ﹤0.01% |
272,310
+129,327
| +90% | +$239K |
|
2869
REX American Resources
REX
$1.46B
| $500K | ﹤0.01% |
31,944
-3,900
| -11% | -$61.2K |
|
|
MDSO
2870
PUT
DELISTED
Medidata Solutions, Inc.
MDSO
| $500K | ﹤0.01% |
6,400
| – | – |
|
2871
Build-A-Bear
BBW
$423M
| $499K | ﹤0.01% |
54,590
+35,338
| +184% | +$333K |
|
2872
CALL
Constellation Brands
STZ
$22.2B
| $499K | ﹤0.01% |
2,500
| – | – |
|
2873
PUT
Travere Therapeutics
TVTX
$5.33B
| $498K | ﹤0.01% |
20,000
| – | – |
|
2874
CALL
Century Aluminum
CENX
$4.57B
| $497K | ﹤0.01% |
30,000
| – | – |
|
2875
Tejon Ranch
TRC
$476M
| $497K | ﹤0.01% |
24,238
-7,338
| -23% | -$147K |
|
Similar funds
D.E. Shaw & Co's Q3 2017 Portfolio in Review
As of Q3 2017, D.E. Shaw & Co held 3,794 positions worth $65.1B, up 7.7% from $60.5B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
D.E. Shaw & Co's Q3 2017 filing shows 469 new, 1,367 increased, 1,237 reduced and 370 closed positions. Its largest new stake was Baker Hughes: 3,076,914 shares worth $113M. The largest sale was Gilead Sciences, an estimated $356M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- D.E. Shaw & Co's largest Q3 2017 buy was Baker Hughes: 3,076,914 shares worth $113M.
- D.E. Shaw & Co added most to Comcast in Q3 2017, an estimated $354M increase.
- D.E. Shaw & Co's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $356M.
- D.E. Shaw & Co fully exited Mobileye N.V. in Q3 2017, selling an estimated $72.4M.
- D.E. Shaw & Co's ten largest holdings make up 9.6% of its $65.1B portfolio in Q3 2017.
- D.E. Shaw & Co opened 469 new positions and closed 370 in Q3 2017.
- D.E. Shaw & Co's portfolio value rose 7.7% quarter-over-quarter to $65.1B.
Based on D.E. Shaw & Co's 13F filing for Q3 2017, filed 14 Nov 2017.